Zhang Xinjing, Wang Xuedong, Wang Liang, Tang Rui, Dong Jiahong
School of Clinical Medicine Department of Hepatopancreatobiliary Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Changping, Beijing, China.
Medicine (Baltimore). 2018 Sep;97(36):e12039. doi: 10.1097/MD.0000000000012039.
Endoscopic placement of multiple plastic stents (MPS) has been the first-line treatment for benign biliary stricture (BBS). Covered self-expanding metal stents (cSEMS) have been used in treatment of BBS; however, the efficacy has not been verified. Therefore, we conducted this meta-analysis according to PRISMA guidelines.
PubMed, Embase, and the Cochrane Library were electronically and manually searched for studies published between January 1, 1990 and April 12, 2017. Of 153 studies screened, 90 were excluded because of duplications. After scanning the title or abstract, only 24 studies were eligible for review and 6 were finally included. The investigators selected publications according to inclusion and exclusion criteria, processed the data, and assessed the quality of the selected studies. The primary endpoint outcome was stricture resolution, and the secondary endpoint outcomes included stricture recurrence rate, the number of endoscopic retrograde cholangiopancreatography (ERCP) sessions, and stent migration.
A total of 6 randomized controlled trials with 330 participants were included in the current meta-analysis. There was no significant difference in stricture resolution between the cSEMS and MPS groups (odds ratio [OR] = 1.05, 95% confidence interval [CI] = 0.53-2.07, I = 29%, P = .23, Z = 0.13, P = .90). Similarly, the stricture recurrence rates (OR = 1.39, 95% CI = 0.69-2.81, I = 38%, P = .17, Z = 0.91, P = .36) were comparable between cSEMS and MPS groups. Stent migration rates (OR = 1.71, 95% CI = 0.84-3.50, I = 4%, P = .241, Z = 1.47, P = .14) were similar between cSEMS and MPS groups. There were fewer ERCP sessions in the cSEMS group than in the MPS group.
This meta-analysis showed that cSEMS were comparable to MPS in achieving resolution of BBSs with fewer ERCP procedures.
内镜下放置多个塑料支架(MPS)一直是良性胆管狭窄(BBS)的一线治疗方法。覆膜自膨式金属支架(cSEMS)已用于BBS的治疗;然而,其疗效尚未得到证实。因此,我们根据PRISMA指南进行了这项荟萃分析。
通过电子和手动检索PubMed、Embase和Cochrane图书馆中1990年1月1日至2017年4月12日发表的研究。在筛选的153项研究中,90项因重复而被排除。在浏览标题或摘要后,只有24项研究符合综述条件,最终纳入6项。研究人员根据纳入和排除标准选择出版物,处理数据,并评估所选研究的质量。主要终点结局是狭窄缓解,次要终点结局包括狭窄复发率、内镜逆行胰胆管造影(ERCP)的次数和支架移位。
本荟萃分析共纳入6项随机对照试验,330名参与者。cSEMS组和MPS组在狭窄缓解方面无显著差异(优势比[OR]=1.05,95%置信区间[CI]=0.53-2.07,I=29%,P=0.23,Z=0.13,P=0.90)。同样,cSEMS组和MPS组的狭窄复发率(OR=1.39,95%CI=0.69-2.81,I=38%,P=0.17,Z=0.91,P=0.36)相当。cSEMS组和MPS组的支架移位率(OR=1.71,95%CI=0.84-3.50,I=4%,P=0.241,Z=1.47,P=0.14)相似。cSEMS组的ERCP次数少于MPS组。
这项荟萃分析表明,cSEMS在实现BBS缓解方面与MPS相当,且ERCP操作次数更少。